SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178913-22-000219
Filing Date
2022-01-24
Accepted
2022-01-24 16:17:47
Documents
1
Period of Report
2022-01-20

Document Format Files

Seq Description Document Type Size
1 zk2227104.html 4  
1 zk2227104.xml 4 3758
  Complete submission text file 0001178913-22-000219.txt   5185
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002
Business Address KIRYAT HADASSAH, MINRAV BUILDING FIFTH FLOOR JERUSALEM L3 9112002 972-2-532-7151
Entera Bio Ltd. (Issuer) CIK: 0001638097 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O ENTERA BIO LTD. KIRYAT HADASSAH, MINRAV BUILDING, 5TH FL JERUSALEM L3 9112002
Business Address
Schwartz Phillip (Reporting) CIK: 0001766208 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38556 | Film No.: 22549564